NCT06420908 Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) Status WITHDRAWN Phase NA
NCT06408584 Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab Status RECRUITING Phase N/A
NCT06401447 TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT06388135 Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE4
NCT06354530 A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2/PHASE3
NCT06354140 PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY Status RECRUITING Phase PHASE2
NCT06333665 PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy Status COMPLETED Phase N/A
NCT06329869 Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06303583 Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT06281886 Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06252974 Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data Status NOT_YET_RECRUITING Phase N/A
NCT06241079 Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma Status COMPLETED Phase N/A
NCT06241066 The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma Status COMPLETED Phase N/A
NCT06225921 Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas Status RECRUITING Phase PHASE1
NCT06194734 A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer Status RECRUITING Phase PHASE3
NCT06192212 PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy Status COMPLETED Phase N/A
NCT06190847 Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer Status RECRUITING Phase N/A
NCT06190782 Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor Status RECRUITING Phase PHASE3